证券代码：600620 证券简称：天宸股份 公告编号：临2025-022 为保证公司经营、管理工作的正常开展，同意公司董事长叶茂菁先生代行总经理职责，自本次董事会审 议通过之日起至公司聘任总经理之日止。公司将按相关规定尽快完成总经理聘任工作。 上海市天宸股份有限公司 关于总经理离任及董事长代行总经理职责 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 上海市天宸股份有限公司（以下简称"公司"）董事会近日收到公司总经理盖剑高先生的书面辞职报告， 盖剑高先生因个人原因申请辞去公司总经理职务及公司下属相关公司的所有职务。辞职后，盖剑高先生 将不在公司及公司下属相关公司担任任何职务。 一、高级管理人员提前离任情况 ■ 二、关于董事长代行总经理职责的事项 公司于2025年7月11日以通讯方式召开第十一届董事会第十三次会议,会议审议并通过了《关于公司董事 长代行总经理职责的议案》，表决结果为9票同意，0票反对，0票弃权。 三、离任对公司的影响 根据《公司法》、《公司章程》等有关规定，盖剑高先生的辞职自辞职报告送达公司董事会之日起生 ...

作者｜酒high 子煜 近期，酒业高管变动频现波澜。 7月初，金种子酒董事、总经理何秀侠辞职，回归华润啤酒总部，而此前侯孝海离任华润啤酒董事会主席。 一个体系内两家酒企的高管变动只是当前酒业管理层流动潮的一个缩影。过去一年来，超10家白酒企业发生核心管理层变更，这场席卷头部酒企与区域品 牌的更替潮，正在酒业深度调整期悄然推进。 离任渐成"常态" 何秀侠的离任轨迹颇具代表性。2022年，金种子酒引入华润战略投资后，何秀侠及多位华润系高管便入驻金种子酒，就任总经理等职位。 彼时，金种子酒连续4年亏损，何秀侠的就任被外界寄予厚望。她曾公开表示，金种子酒一定会再创辉煌，重回皖酒第一阵营。但三年任期未满，企业业 绩不升反降。 财报数据显示，2024年，金种子酒实现营收9.25亿元，同比下跌37.04%，亏损2.58亿元，较2023年亏损额下滑超10倍。也正是这一预期背离，引发外界关 于何秀侠离任原因的猜测。 根据金种子酒公告，何秀侠原定任期是到今年的11月21日，提前离任的原因是"工作调整"。 | 姓名 | 离任职务 | 离任时间 | 原定任期到 | 离任原因 | 是否继续在上 | 是否存在未 | | --- | -- ...

2025年的日历翻过一半，中国资本市场的浪潮依然奔涌不息。作为市场核心中介与"看门人"，证券公司 的一举一动，深刻映射着金融生态的脉动。 这个半年，全面注册制深化推进，IPO受理持续回暖，市场活力持续激发。潮水之下，我们关注到，有 些券商在业务狂奔中触碰红线，有些券商"走马换将"的人事变动频繁上演。 即日起，南都·湾财社将推出2025上半年券商行业系列报道。穿透数据表象，深入剖析违规惩戒的警示 意义、人事变动的深层逻辑、IPO市场的真实温度，勾勒一幅更为立体的券商行业半年图景。 2025 年上半年，券商行业的人事变动浪潮汹涌而至。据Wind平台与公司公告显示，截至6月30 日，已 有41家券商的 "董监高" 成员发生变动，涉及离职、新聘等多种情况，变动频次高达214次。 无论是上市券商还是未上市的中腰部券商，都卷入了这场人事调整的棋局，其中在重组浪潮中备受关注 的几家券商，更是在人事布局上动作频频。多家券商还进行了"董事长"的变动，新的掌舵人又将为行业 格局演变带来哪些影响？ 券商行业人事变动： 41家券商变动214频次 步入2025年，券商整体的人事调整尤为频繁，有人因年龄，到龄退休；有人因个人原因，另谋出 ...

Group 1 - Tong Ren Tang's Executive Vice President Zhang Chunyou submitted a resignation letter, effective July 8, 2025, due to work adjustments, while remaining as General Manager of Tong Ren Tang Technology [1] - The company stated that Zhang Chunyou's departure will not adversely affect daily operations, indicating limited market impact from this internal personnel adjustment [1] Group 2 - Basestone Pharmaceuticals announced an exclusive strategic partnership with Istituto Gentili for the commercialization of Sugliant in Western Europe and the UK, granting Gentili exclusive rights in 23 countries [2] - Basestone will receive up to $192.5 million in payments, including upfront, registration, and sales milestone payments, along with nearly 50% revenue sharing from net sales in the authorized region [2] - This collaboration enhances Basestone's international market recognition and strengthens investor confidence in future growth [2] Group 3 - Fosun Pharma announced guarantees for its subsidiaries, providing a maximum joint liability guarantee for a financing application not exceeding 500 million yuan with Bank of China [3] - Additionally, a guarantee was provided for a financing contract not exceeding 150 million yuan with China Construction Bank for its subsidiary Hanlin Pharmaceutical [3] - This move supports subsidiaries in obtaining funds for business expansion or R&D, although it introduces certain financial risks [3] Group 4 - Run Da Medical responded to the Shanghai Stock Exchange's inquiry regarding its 2024 annual report, addressing issues related to operating performance, goodwill, short-term solvency, and prepayments [4] - The response aims to alleviate market concerns and stabilize investor confidence, although ongoing monitoring of the company's performance improvement measures is necessary [4] Group 5 - Yuan Da Pharmaceutical announced that its joint venture Sirtex Medical Pty Ltd received FDA approval for SIR-Spheres Yttrium-90 microspheres for treating unresectable hepatocellular carcinoma (HCC) [5] - This product is the first and only FDA-approved selective internal radiation therapy for both unresectable HCC and colorectal cancer liver metastases [5] - This breakthrough enhances Yuan Da's market position in oncology and boosts investor confidence in future growth [5]

Group 1 - The company held its third board meeting on July 5, 2025, with all seven directors present, and the meeting complied with relevant laws and regulations [1] - The board approved a proposal to change the registered capital and amend the Articles of Association, resulting in an increase in total share capital from 100 million shares to approximately 129.74 million shares after a capital reserve conversion [1] - The company will no longer have a supervisory board, with its functions transferred to the audit committee of the board, and relevant rules will be amended accordingly [2] Group 2 - The board approved the election of Zhu Weigang as a representative director from the employee representative assembly, following the resignation of Jin Xiaoyan due to personal reasons [5] - The company plans to reappoint Tianjian Accounting Firm as the auditing institution for the year 2025, pending approval at the upcoming extraordinary general meeting [7] - The board proposed to hold the 2025 first extraordinary general meeting on July 23, 2025, with all seven votes in favor of the proposal [7]

Core Points - National Investment Corporation (国投资本) has undergone significant leadership changes, with General Manager Lu Jun resigning on July 2, 2024, and Chairman Cui Hongqin taking over his responsibilities temporarily [2][3] - The company has four major financial segments: securities, trust, fund, and futures, with National Investment Securities (国投证券) reversing a two-year profit decline due to strong proprietary trading performance [2][11] - The trust and futures segments continue to face profit declines, while the fund business is experiencing both scale and performance pressures [2][11] Leadership Changes - Lu Jun, who served as General Manager for only 1 year and 2 months, has left for a work transfer, and Cui Hongqin has been elected as the new Chairman [3][24] - Cui Hongqin has extensive financial management experience and previously held various senior positions within the National Development Investment Group [3][24] - The former Chairman, Duan Wenwu, has transitioned to a role at China Minmetals and is expected to resign from his position as Chairman of National Investment Securities soon [5][24] Business Performance - National Investment Securities reported a revenue of 10.78 billion yuan in 2024, a 1.95% increase year-on-year, with a net profit of 2.53 billion yuan, up 30.49% [11][23] - The significant profit increase is attributed to a remarkable 834.62% rise in proprietary trading income, while other business segments like brokerage and asset management saw declines [11][12] - The overall revenue for National Investment Corporation in 2024 was 15.06 billion yuan, a decrease of 13.76%, marking the lowest level in four years [23] Segment Analysis - National Investment Securities accounts for over 71.62% of National Investment Corporation's revenue, highlighting its critical role in the overall business [11][23] - The trust segment, National Investment Taikang Trust, reported a revenue decline of 22.17% to 1.466 billion yuan, and net profit fell by 29.75% [16][23] - National Investment Futures has faced a continuous decline in net profit for three consecutive years, with a reported net profit of 215 million yuan in 2024, down 15.69% [20][21] Market Environment - The performance of National Investment Corporation's various segments reflects the broader market conditions, with the securities sector benefiting from a recovering market while trust and futures face challenges [23][24] - The recent leadership changes may impact the company's strategic direction and operational stability, raising concerns about team cohesion and market confidence [23][24]

| | 外部引入 | 内部提拔 | | --- | --- | --- | | 国有行 | 87.5% | 12.5% | | 股份行 | 22% | 78% | 2025年行至中途，伴随经营战略转型推进，银行业高管变阵持续显现。南都湾财社记者根据6家国有行 和12家股份行公告不完全统计发现，2025年上半年共13家银行发生高管换新，17位高管完成岗位更迭， 其中"副行长"一职变动最为频繁，占全部变动职位的53%。与此同时，有3家银行董事长易主，3家银行 行长换新。 值得关注的是，国有行与股份行呈现截然不同的用人策略，国有行中87.5%的新任高管由外部引入，股 份行则以内部提拔(含机构系统及集团内提拔)为主，占78%。 年龄结构上，新晋者中"70后"成为中坚力量，"80后"新生力量崭露头角，董事长多由"60后"担任，行长 及副行长岗位则以"70后"为主。 上半年13家银行高管换新 "副行长"一职变动频繁 2025年以来，银行业人事变动频繁，多家银行高管职位换新。南都湾财社记者根据各银行公告不完全统 计发现，2025上半年以来，在6家国有行和12家股份行中，已有5家国有行与8家股份制银行相继发布高 层职务调整公 ...

Core Insights - The Chinese financial industry is undergoing significant changes in the first half of 2025, with a focus on reform and innovation across banking, insurance, securities, and consumer finance sectors [2] - A total of 13 banks experienced executive changes, with 17 executives transitioning into new roles, highlighting a trend of frequent leadership adjustments [3][4] - There is a notable difference in hiring strategies between state-owned banks and joint-stock banks, with state-owned banks predominantly hiring externally while joint-stock banks favor internal promotions [6][9] Executive Changes - In the first half of 2025, 13 banks saw executive changes, with 17 executives changing positions, including 8 from state-owned banks and 9 from joint-stock banks [3][4] - The position of vice president saw the most changes, with 9 new appointments, accounting for 53% of all changes [3] - Key leadership changes included new chairpersons and presidents at several banks, such as Postal Savings Bank, Guangfa Bank, and Huaxia Bank [3][5] Hiring Strategies - State-owned banks have a strong tendency to recruit from external sources, with 87.5% of new executives coming from outside the organization [6][9] - In contrast, joint-stock banks primarily promote from within, with 78% of new executives being internal promotions [6][9] - This difference in hiring strategies reflects the distinct operational needs and talent pools of state-owned versus joint-stock banks [9] Age Demographics of New Executives - The new executive cohort is predominantly composed of individuals born in the 1970s, who make up nearly 78% of the new appointments in state-owned banks [10] - The youngest new executive is 50 years old, while the oldest is 58, indicating a trend of experienced leadership [10][11] - In joint-stock banks, the age distribution includes both seasoned leaders and younger talent, with a significant presence of 70s-born executives [11]

继洋河集团之后，洋河股份再现重大人事变动。 7月1日，洋河股份公告，董事长张联东因工作调整离任。 张联东 张联东突然卸任！一周前还与刘强东沙漠对饮 据洋河股份官方微博，此番卸任前一周，张联东还和老乡刘强东相聚沙漠为自家新推的光瓶酒站台。 （左一为张联东） 据 国际金融报报道， 张联东已执掌洋河4年多。他的职业履历较为丰富，早期在宿迁市支口乡担任党委组织干事、组织委员，后升任宿城区经 济开发区管委会主任、招商局局长等职。随后，其相继担任宿城区副区长、宿迁市政府副秘书长等职位。 2021年初，张联东的职业轨迹发生重大转变， 他从政府官员转型为国企掌门人，空降至洋河股份，担任公司党委副书记。 次月，在洋河股份 第七届董事会第一次会议上，张联东被选举为公司第七届董事会董事长。 在任期间业绩坐"过山车" 在张联东任期内，洋河股份业绩出现"过山车"，既有2022年和2023年业绩快速增长，净利润突破百亿元大关，创造历史；也有2024年及2025 年（一季度）业绩快速回落，净利润同比大幅下滑。 | 002304 图文F10 | | | | | | | --- | --- | --- | --- | --- | --- | ...

市场消息：美联储最高气候官员Kevin Stiroh离职。 ...